Product Information
TIROSINT 37.5 MCG CAPSULE is a brand product labeled by IBSA Pharma Inc., priced at $4.5571 per EA under NDC 71858001204. Its NADAC has been published 29 times since Mar 20, 2024.
The High Outlier badge above means this manufacturer's average price in the levothyroxine sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
37.5 ug/1
Manufacturer
IBSA Pharma Inc.NDC
71858001204
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
7/1/2024
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021924On Market Since
3/1/2023
Pharmacological Classes
Price Statistics
The NADAC for TIROSINT 37.5 MCG CAPSULE has been published 29 times since Mar 20, 2024, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5571 per EA |
|---|---|
| All-time high | $4.5571 (Oct 2, 2024) |
| All-time low | $4.3899 (Apr 17, 2024) |
| Median price | $4.5571 |
| Average price | $4.4805 |
| Largest weekly change | +3.7% (Jun 26, 2024) |
| Weeks tracked | 29 |
| Tracking since | Mar 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the levothyroxine sodium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TIROSINT 37.5 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIROSINT 37.5 MCG CAPSULE, manufactured by IBSA Pharma Inc., is $4.5571 per EA (NDC 71858001204), effective Oct 2, 2024.
How has the price of TIROSINT 37.5 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIROSINT 37.5 MCG CAPSULE has risen 3.3%. It has been tracked across 29 weekly CMS publications since Mar 20, 2024.
What are the highest and lowest recorded NADAC prices for TIROSINT 37.5 MCG CAPSULE?
Since Mar 20, 2024, the NADAC for TIROSINT 37.5 MCG CAPSULE has ranged from a low of $4.3899 (Apr 17, 2024) to a high of $4.5571 (Oct 2, 2024), with a median of $4.5571 per EA.
Are there cheaper alternatives to TIROSINT 37.5 MCG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TIROSINT 37.5 MCG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures TIROSINT 37.5 MCG CAPSULE?
TIROSINT 37.5 MCG CAPSULE (NDC 71858001204) is labeled by IBSA Pharma Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification